FDA Drug Approval Decisions Expected in March 2024
The PDUFA date refers to the deadline set by the US Food and Drug Administration for reviewing drug applications.
Source: empr.com
Page 36 - Priority Review News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Priority Review. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Priority Review Today - Breaking & Trending Today
Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results
Fourth-Quarter and Full-Year Sales Reflect Sustained Growth Across Oncology and Vaccines Fourth-Quarter Worldwide Sales Were $14.6 Billion, an Increase of 6% From Fourth Quarter 2022; Excluding...
Source: marketscreener.com
Long Time Coming: Pediatric Gastroenterologists React to New Dupilumab EoE Approval
Following the January 25, 2024 approval of dupilumab for eosinophilic esophagitis in patients 1-11 years of age, a trio of pediatric gastroenterologists shares their thoughts on the new indication, their anticipated priority of use, and potential hurdles to optimal treatment uptake.
Source: hcplive.com
Merck beats analyst's sales estimates | Southeastern Pennsylvania
Merck stock jumped to a 52-week high at the opening of trading Thursday morning after the company released fourth quarter and full year results.
Source: wfmz.com
FDA Grants Priority Review to Expand Liso-Cel Indications in R/R Follicular Lymphoma and MCL
Liso-cel sBLAs for indications in relapsed/refractory FL and MCL after exposure to a BTK inhibitor have received priority review from the FDA.
Source: onclive.com